William David A.

William David A. has a diverse work experience spanning multiple industries. William David has held various leadership positions in prominent companies, including TELA Bio, ICONIX LIMITED, Otivio AS, Ablatus Therapeutics, SurgaColl Holdings Ltd, Vascular Flow Technologies, Active Needle Technology Ltd., Stryker Orthobiologics, AngioDynamics, and Smith+Nephew Wound.

William David served as Vice President at TELA Bio and Director at ICONIX LIMITED. Additionally, they were a Non-Executive Director at Otivio AS and Chair at Ablatus Therapeutics.

William David A. was the CEO of SurgaColl Holdings Ltd, where they contributed to the development and manufacturing of regenerative products for orthopedic defects. William David also held the CEO position at Vascular Flow Technologies, contributing to the growth of the company.

Furthermore, they served as the Chairperson at Active Needle Technology Ltd. and held the role of VP and General Manager- International Operations at Stryker Orthobiologics.

Prior to that, William David A. was the Managing Director of International Operations for AngioDynamics, overseeing various departments such as sales, marketing, finance, and manufacturing. William David also had a significant role at Smith+Nephew Wound, serving as Global Vice-President for Marketing and later as Global Vice President for WBP and Core Brands.

Overall, William David A. has demonstrated strong leadership and expertise in various areas, including regenerative products, medical devices, marketing, and international operations.

William David A. has a Bachelor of Dental Surgery degree in Oral Surgery from The University of Edinburgh. William David also holds a Master of Business Administration (MBA) degree in Business Administration from the University of Cape Town. In addition, they obtained an Advanced Management Program (AMP) certification in Business Administration from INSEAD. William David is certified in Dental Surgery by the Health Professions Council and the General Dental Council.